BUYOUT OF OTHER ROYALTY-BEARING PRODUCT ROYALTIES Sample Clauses

BUYOUT OF OTHER ROYALTY-BEARING PRODUCT ROYALTIES. ALZA shall have the option, in its discretion, at any time from and after the end of the twelfth full calendar quarter following the first commercial sale in each country of any Other Royalty-Bearing Product, to buy out its remaining obligation to make payments under Section 7.4 with respect to sales of such other Royalty-Bearing Product in such country. The buyout price shall be an amount equal to 15 times the payments made by or due to TDC from ALZA under Section 7.4 with respect to sales of such other Royalty-Bearing Product in such country during the four most recent calendar quarters preceding the date of exercise of the buyout option for which royalties were paid or were due in respect of such country. ALZA shall have the option, in its discretion, at any time from and after the end of the twelfth full calendar quarter following the first commercial sale of any Other Royalty-Bearing Product as to which payments are due under Section 7.4 in either the United States or two other Major Market Countries, to buy out its remaining worldwide obligations to make payments under Section 7.4 with respect to such Other Royalty-Beating Product. The buyout price shall be an amount equal to 20 times the payments made by or due to TDC from ALZA under Section 7.4 during the four most recent calendar quarters preceding the date of exercise of the buyout option for which royalties were paid or were due on a worldwide basis with respect to such Other Royalty-Bearing Product under Section 7.4 (and, in addition, such payments as would have been paid by or due from ALZA to TDC if ALZA had not exercised any country-specific buyout option with respect to such Other Royalty-Bearing Product) less any amounts previously paid to exercise any country-specific buyout option with respect to such Other Royalty-Bearing Product.
AutoNDA by SimpleDocs

Related to BUYOUT OF OTHER ROYALTY-BEARING PRODUCT ROYALTIES

  • Net Sales The term “

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Earned Royalty In addition, Alnylam will pay Stanford earned royalties on Net Sales as follows:

  • Royalties 8.1 In consideration of the license herein granted, LICENSEE shall pay royalties to LICENSOR as follows:

  • Royalty 8.1 In consideration of the rights granted under clause 2, the Licensee shall pay to the Licensor royalties, on each twelve month time period, first calculated from the date of execution of this Agreement, and calculated on a scale as follows:

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount:

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

Time is Money Join Law Insider Premium to draft better contracts faster.